| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 129.46B | 128.14B | 125.74B | 123.50B | 109.92B | 88.22B |
| Gross Profit | 24.69B | 24.32B | 21.88B | 20.35B | 18.92B | 16.81B |
| EBITDA | 15.13B | 16.42B | 15.35B | 11.73B | 10.23B | 9.68B |
| Net Income | 6.98B | 7.37B | 6.88B | 4.56B | 3.94B | 3.23B |
Balance Sheet | ||||||
| Total Assets | 114.53B | 116.47B | 115.65B | 112.00B | 102.64B | 95.21B |
| Cash, Cash Equivalents and Short-Term Investments | 23.43B | 24.47B | 21.88B | 23.48B | 20.70B | 21.11B |
| Total Debt | 12.06B | 11.80B | 10.15B | 10.58B | 9.86B | 10.29B |
| Total Liabilities | 41.59B | 40.69B | 41.63B | 39.84B | 37.19B | 34.13B |
| Stockholders Equity | 63.41B | 64.87B | 64.44B | 63.20B | 57.76B | 53.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.25B | 6.50B | 4.54B | 1.84B | 5.79B |
| Operating Cash Flow | 0.00 | 11.55B | 10.75B | 8.52B | 4.57B | 9.39B |
| Investing Cash Flow | 0.00 | -3.15B | -1.67B | -3.96B | -2.44B | -3.00B |
| Financing Cash Flow | 0.00 | -6.51B | -11.12B | -2.34B | -2.95B | -2.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥86.39B | 8.29 | ― | 3.06% | 2.02% | 30.10% | |
79 Outperform | ¥41.71B | 9.83 | ― | 0.13% | 9.78% | 40.00% | |
76 Outperform | ¥40.56B | 5.81 | ― | 3.53% | -3.45% | 30.52% | |
67 Neutral | ¥102.84B | 11.35 | ― | 3.88% | 2.61% | 30.29% | |
66 Neutral | ¥26.34B | 10.33 | ― | 3.53% | 6.99% | -0.30% | |
65 Neutral | ¥81.43B | 17.82 | ― | 0.67% | 10.18% | -14.36% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |